Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity
Diabetes represents a major health problem, involving a severe imbalance of blood sugar levels, which can disturb the nerves, eyes, kidneys, and other organs. Diabes management involves several synthetic drugs focused on improving insulin sensitivity, increasing insulin production, and decreasing blood glucose levels, but with unclear molecular mechanisms and severe side effects. Natural chemicals extracted from several plants such as <i<Gymnema sylvestre, Momordica charantia</i< or <i<Ophiopogon planiscapus Niger</i< have aroused great interest for their anti-diabetes activity, but also their hypolipidemic and anti-obesity activity. Here, we focused on the anti-diabetic activity of a few natural and synthetic compounds, in correlation with their pharmacokinetic/pharmacodynamic profiles, especially with their blood-brain barrier (BBB) permeability. We reviewed studies that used bioinformatics methods such as predicted BBB, molecular docking, molecular dynamics and quantitative structure-activity relationship (QSAR) to elucidate the proper action mechanisms of antidiabetic compounds. Currently, it is evident that BBB damage plays a significant role in diabetes disorders, but the molecular mechanisms are not clear. Here, we presented the efficacy of natural (gymnemic acids, quercetin, resveratrol) and synthetic (TAK-242, propofol, or APX3330) compounds in reducing diabetes symptoms and improving BBB dysfunctions. Bioinformatics tools can be helpful in the quest for chemical compounds with effective anti-diabetic activity that can enhance the druggability of molecular targets and provide a deeper understanding of diabetes mechanisms..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Biomolecules - 11(2021), 11, p 1692 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ana Maria Udrea [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Blood–brain barrier |
|---|
| doi: |
10.3390/biom11111692 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ008686521 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ008686521 | ||
| 003 | DE-627 | ||
| 005 | 20240412132844.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biom11111692 |2 doi | |
| 035 | |a (DE-627)DOAJ008686521 | ||
| 035 | |a (DE-599)DOAJa674b248573d4912bc616f7e3586ebe6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a QR1-502 | |
| 100 | 0 | |a Ana Maria Udrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Diabetes represents a major health problem, involving a severe imbalance of blood sugar levels, which can disturb the nerves, eyes, kidneys, and other organs. Diabes management involves several synthetic drugs focused on improving insulin sensitivity, increasing insulin production, and decreasing blood glucose levels, but with unclear molecular mechanisms and severe side effects. Natural chemicals extracted from several plants such as <i<Gymnema sylvestre, Momordica charantia</i< or <i<Ophiopogon planiscapus Niger</i< have aroused great interest for their anti-diabetes activity, but also their hypolipidemic and anti-obesity activity. Here, we focused on the anti-diabetic activity of a few natural and synthetic compounds, in correlation with their pharmacokinetic/pharmacodynamic profiles, especially with their blood-brain barrier (BBB) permeability. We reviewed studies that used bioinformatics methods such as predicted BBB, molecular docking, molecular dynamics and quantitative structure-activity relationship (QSAR) to elucidate the proper action mechanisms of antidiabetic compounds. Currently, it is evident that BBB damage plays a significant role in diabetes disorders, but the molecular mechanisms are not clear. Here, we presented the efficacy of natural (gymnemic acids, quercetin, resveratrol) and synthetic (TAK-242, propofol, or APX3330) compounds in reducing diabetes symptoms and improving BBB dysfunctions. Bioinformatics tools can be helpful in the quest for chemical compounds with effective anti-diabetic activity that can enhance the druggability of molecular targets and provide a deeper understanding of diabetes mechanisms. | ||
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a natural compounds | |
| 650 | 4 | |a QSAR | |
| 650 | 4 | |a molecular docking | |
| 650 | 4 | |a molecular dynamics | |
| 650 | 4 | |a blood–brain barrier | |
| 653 | 0 | |a Microbiology | |
| 700 | 0 | |a Gratiela Gradisteanu Pircalabioru |e verfasserin |4 aut | |
| 700 | 0 | |a Anca Andreea Boboc |e verfasserin |4 aut | |
| 700 | 0 | |a Catalina Mares |e verfasserin |4 aut | |
| 700 | 0 | |a Andra Dinache |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Mernea |e verfasserin |4 aut | |
| 700 | 0 | |a Speranta Avram |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Biomolecules |d MDPI AG, 2013 |g 11(2021), 11, p 1692 |w (DE-627)DOAJ000114170 |x 2218273X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:11, p 1692 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/biom11111692 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a674b248573d4912bc616f7e3586ebe6 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2218-273X/11/11/1692 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2218-273X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 11, p 1692 | ||